SCHEMBL6744485

SCHEMBL6744485

CC(=O)C(CC(=O)O)CC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.45
TDP1 Q9NUW8 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 2/20 0.40
MME P08473 2/20 0.39
MAPT P10636 1/20 0.39
CPA1 P15085 2/20 0.38
ALOX15 P16050 1/20 0.38
CPB1 P15086 1/20 0.38
CPA3 P15088 1/20 0.38
CPB2 Q96IY4 1/20 0.38
GABRR1 P24046 2/20 0.38
FFAR3 O14843 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27543712 0.92 TDP1 (0.43) FOLH1SLC22A6TDP1SMN1; SMN2LMNA
SCHEMBL6844224 0.86 USP2 (0.42) FOLH1SLC22A6TDP1SMN1; SMN2LMNA
SCHEMBL9270192 0.86 MME (0.44) FOLH1SLC22A6TDP1SMN1; SMN2LMNA
SCHEMBL22472016 0.84 USP2 (0.41) FOLH1SLC22A6TDP1SMN1; SMN2LMNA
SCHEMBL22472002 0.84 USP2 (0.41) FOLH1SLC22A6TDP1SMN1; SMN2LMNA
SCHEMBL4170332 0.82 CHRM1 (0.54) FOLH1TDP1
SCHEMBL10000266 0.82 MME (0.55) FOLH1TDP1MMECPA1
SCHEMBL25401621 0.81 FOLH1 (0.46) FOLH1SLC22A6TDP1SMN1; SMN2LMNA
SCHEMBL8532702 0.80 FOLH1 (0.37) FOLH1SLC22A6TDP1SMN1; SMN2LMNA
SCHEMBL15080402 0.80 SLC1A3 (0.44) FOLH1SLC22A6TDP1MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040086949-A1 Method for preparing a ligand presenting assembly (LPA), an LPA and uses thereof STATENS SERUM INSTITUT 2004-05-06 US claimed
EP-1117677-B1 LIGAND PRESENTING ASSEMBLY (LPA), METHOD OF PREPARATION AND USES THEREOF STATENS SERUMINSTITUT (DK) 2003-11-12 EP claimed
EP-1117677-A1 LIGAND PRESENTING ASSEMBLY (LPA), METHOD OF PREPARATION AND USES THEREOF Statens Serum Institut (DK) 2001-07-25 EP claimed
WO-2000018791-A1 LIGAND PRESENTING ASSEMBLY (LPA), METHOD OF PREPARATION AND USES THEREOF STATENS SERUM INSTITUT (DK) 2000-04-06 WO claimed
CN-101027319-A Heparin binding peptide ENKAM PHARMACEUTICALS AS (DK) 2007-08-29 CN disclosed
CN-101027320-A FGFR binding peptides ENKAM PHARMACEUTICALS AS (DK) 2007-08-29 CN disclosed
CN-1863820-A Compounds comprising lpa ENKAM PHARMACEUTICALS AS (DK) 2006-11-15 CN disclosed
US-20040086949-A1 Method for preparing a ligand presenting assembly (LPA), an LPA and uses thereof STATENS SERUM INSTITUT 2004-05-06 US disclosed
EP-1117677-B1 LIGAND PRESENTING ASSEMBLY (LPA), METHOD OF PREPARATION AND USES THEREOF STATENS SERUMINSTITUT (DK) 2003-11-12 EP disclosed
EP-1117677-A1 LIGAND PRESENTING ASSEMBLY (LPA), METHOD OF PREPARATION AND USES THEREOF Statens Serum Institut (DK) 2001-07-25 EP disclosed
WO-2000018791-A1 LIGAND PRESENTING ASSEMBLY (LPA), METHOD OF PREPARATION AND USES THEREOF STATENS SERUM INSTITUT (DK) 2000-04-06 WO disclosed
US-4883857-A Production of photodegradable polyester plastics ECOPLASTICS LIMITED (CA) 1989-11-28 US disclosed
WO-1989002903-A1 PRODUCTION OF PHOTODEGRADABLE POLYESTER PLASTICS ECOPLASTICS LIMITED (CA) 1989-04-06 WO disclosed
US-4066667-A 9-Hydroxy-7,8,9,10-tetrahydro-6H, dibenzo[b][d] pyrans and pyranones ABBOTT LABORATORIES (US) 1978-01-03 US disclosed